Literature DB >> 27366477

What Do Current Information and Evidence Suggest to Us for Oxytocin Use During Caesarean Section?

Berrin Günaydın1, Ayça Taş Tuna2.   

Abstract

Oxytocin is the first-line agent in the prevention and treatment of uterine atony and maintenance of uterine tone. Since there are several different practices related to the use of oxytocin during caesarean sections, we would like to address the latest information and evidence for rational oxytocin use.

Entities:  

Keywords:  Oxytocin; caesarean section; current information

Year:  2015        PMID： 27366477      PMCID： PMC4917151          DOI： 10.5152/TJAR.2014.76753

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN： 2149-276X


  13 in total

1.  Oxytocin protocols during cesarean delivery: time to acknowledge the risk/benefit ratio?

Authors:  Lawrence C Tsen; Mrinalini Balki
Journal:  Int J Obstet Anesth       Date:  2010-06-08       Impact factor: 2.603

2.  The use of uterotonic drugs during caesarean section.

Authors:  R A Dyer; D van Dyk; A Dresner
Journal:  Int J Obstet Anesth       Date:  2010-07       Impact factor: 2.603

3.  Minimum oxytocin dose requirement after cesarean delivery for labor arrest.

Authors:  Mrinalini Balki; Michael Ronayne; Sharon Davies; Shafagh Fallah; John Kingdom; Rory Windrim; José C A Carvalho
Journal:  Obstet Gynecol       Date:  2006-01       Impact factor: 7.661

4.  Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony.

Authors:  Chad A Grotegut; Michael J Paglia; Lauren N C Johnson; Betty Thames; Andra H James
Journal:  Am J Obstet Gynecol       Date:  2010-11-03       Impact factor: 8.661

Review 5.  Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.

Authors:  Robert A Dyer; Alexander J Butwick; Brendan Carvalho
Journal:  Curr Opin Anaesthesiol       Date:  2011-06       Impact factor: 2.706

6.  Intravenous oxytocin in patients undergoing elective cesarean section.

Authors:  M C Sarna; A K Soni; M Gomez; N E Oriol
Journal:  Anesth Analg       Date:  1997-04       Impact factor: 5.108

7.  Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section.

Authors:  J S Thomas; S H Koh; G M Cooper
Journal:  Br J Anaesth       Date:  2006-12-02       Impact factor: 9.166

Review 8.  Oxytocin and parturition: a role for increased myometrial calcium and calcium sensitization?

Authors:  Patrice Arthur; Michael J Taggart; Bryan F Mitchell
Journal:  Front Biosci       Date:  2007-01-01

9.  Oxytocin requirements at elective cesarean delivery: a dose-finding study.

Authors:  José C A Carvalho; Mrinalini Balki; John Kingdom; Rory Windrim
Journal:  Obstet Gynecol       Date:  2004-11       Impact factor: 7.661

10.  Oxytocin pretreatment of pregnant rat myometrium reduces the efficacy of oxytocin but not of ergonovine maleate or prostaglandin F 2 alpha.

Authors:  Mrinalini Balki; Alexandra L Cristian; John Kingdom; Jose C A Carvalho
Journal:  Reprod Sci       Date:  2010-02-02       Impact factor: 3.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.